Samsung Biologics seeks to expand partnerships in New York
John Rim, CEO of Samsung Biologics, delivers a speech during the J.P. Morgan Healthcare Conference in San Francisco, Jan. 12. Samsung Biologics said Thursday the CEO will take part in DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York, from March 20 to 23. Courtesy of Samsung BiologicsBy Baek Byung-yeulSamsung Biologics will take part in 2023 DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York from March 20 to 23, in a bid to seek more partnerships, the company said Thursday.Hosted by the Drug, Chemical & Associated Technologies Association (DCAT), DCAT Week has been a representative networking event in the pharmaceutical industry since 1890.More than 90 percent of the participants are high-level executives who are directly in charge of making decisions, so the event is regarded as a place to intensively discuss partnerships between companies.A total of more than 700 companies and over 10,000 participants from around 50 countries joined the 2022 event and about 12,000 people are expec
